Wells Fargo
CCEL icon

Wells Fargo’s Cryo-Cell International CCEL Stock Holding History

Wells Fargo’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-29
Closed -$216 – 6967
2024
Q1 		$216 Hold
29
– – ﹤0.01% 6481
2023
Q4 		$167 Buy
29
+2
+7% +$10 ﹤0.01% 6649
2023
Q3 		$142 Buy
27
+2
+8% +$12 ﹤0.01% 6667
2023
Q2 		$152 Hold
25
– – ﹤0.01% 6771
2023
Q1 		$76 Buy
25
+1
+4% +$4 ﹤0.01% 6999
2022
Q4 		$102 Buy
24
+1
+4% +$5 ﹤0.01% 6786
2022
Q3 		$0 Buy
23
+5
+28% +$31 ﹤0.01% 6706
2022
Q2 		$0 Sell
18
-499
-97% -$3.19K ﹤0.01% 6846
2022
Q1 		$4K Buy
517
+500
+2,941% +$4.61K ﹤0.01% 6513
2021
Q4 		$0 Sell
17
-483
-97% -$6.02K ﹤0.01% 7252
2021
Q3 		$6K Buy
+500
New +$6.16K ﹤0.01% 6325

Other funds holding CCEL

HLA
Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return
SA
SFI Advisors Montclair, New Jersey $95.2M AUM 23.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
RP
Rowlandmiller & Partners Atlanta, Georgia $549M AUM 36.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo's CCEL Position: Q2 2024 in Review

Wells Fargo sold out of Cryo-Cell International (CCEL) in Q2 2024, closing a stake of 29 shares — an estimated $216 sold.

Wells Fargo first reported a position in CCEL in Q3 2021 and held it in 11 quarters. The position peaked at $6K in Q3 2021. 14 funds tracked by Wall St. Rank hold CCEL as of Q2 2024.

  • Wells Fargo reported no remaining Cryo-Cell International position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 29 Cryo-Cell International shares in Q2 2024, an estimated $216.
  • Wells Fargo first reported a position in Cryo-Cell International in Q3 2021 and held it in 11 quarters.
  • Wells Fargo's Cryo-Cell International position peaked at $6K in Q3 2021.
  • 14 funds tracked by Wall St. Rank held Cryo-Cell International as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.